Christopher Hite, Chairman of Royalty Pharma RPRX, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $14M. The latest trade was on 09/22.

Christopher Hite

EVP & Chairman, Partnering

Company

Royalty Pharma RPRX

First filing

24/05/16

Trades

16 trades

Buys / sales

0 / 4

12-month net buying

−$14M

Last trade

09/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Royalty PharmaRPRX	Open-market sale10b5-1 plan	09/22	09/24	100,000 sh2 trades	$58.53avg.	$5,853,095.17	−27.0%
Royalty PharmaRPRX	Open-market sale10b5-1 plan	06/23	06/25	150,000 sh2 trades	$54.39avg.	$8,158,833.12	−21.1%